Cognitive-Behavioral Therapy for Bipolar Disorder, Second Edition

From leading scientist-practitioners, this pragmatic, accessible book provides a complete framework for individualized assessment and treatment of bipolar disorder. It addresses the complexities of working with individuals with broadly varying histories and clinical presentations, including those who have been recently diagnosed, those who are symptomatically stable, and those who struggle day to day to achieve symptom remission. Extensive case material illustrates proven strategies for conceptualizing patients' needs and working collaboratively to help them adhere to medication treatments, recognize the early warning signs of manic and depressive episodes, build coping skills, and manage specific symptoms. The second edition is a complete revision of the original volume, updated and restructured to be even more user friendly for clinicians.

Monica Ramirez Basco, PhD, a clinical psychologist, is Associate Director for Science Policy, Planning, and Analysis at the Office of Research on Women’s Health at the National Institutes of Health. She served as Assistant Director for Neuroscience, Mental Health, and Broadening Participation at the White House Office of Science and Technology Policy from 2014 to 2015. Dr. Basco is an internationally recognized expert in cognitive-behavioral therapy and a founding fellow of the Academy of Cognitive and Behavioral Therapies. She was formerly on the faculty of the University of Texas at Arlington, where she was awarded the University of Texas Regents’ Outstanding Teaching Award.

 

A. John Rush, MD, is Professor of Psychiatry and Vice Chair, Department of Clinical Sciences, at the University of Texas Southwestern Medical Center at Dallas. His work has focused on the diagnosis and psychotherapeutic, psychopharmacological, and somatic treatment of depression and other mood disorders. He has authored 10 books and over 400 journal articles. Dr. Rush's internationally recognized work has received numerous awards. Most recently, his research has focused on longer-term disease management programs, including multistep treatment algorithms for bipolar and major depressive disorders.